Nephro-Urology Monthly

Published by: Kowsar

Evaluation of Renal-Hepatic Functional Indices and Blood Pressure Based on the Progress of Time in a Rat Model of Chronic Kidney Disease

Hassan Askari 1 , Behjat Seifi 1 , * and Mehri Kadkhodaee 1
Authors Information
1 Department of Physiology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Nephro-Urology Monthly: May 01, 2016, 8 (3); e37840
  • Published Online: April 26, 2016
  • Article Type: Research Article
  • Received: March 14, 2016
  • Accepted: April 9, 2016
  • DOI: 10.5812/numonthly.37840

To Cite: Askari H, Seifi B, Kadkhodaee M. Evaluation of Renal-Hepatic Functional Indices and Blood Pressure Based on the Progress of Time in a Rat Model of Chronic Kidney Disease, Nephro-Urol Mon. 2016 ; 8(3):e37840. doi: 10.5812/numonthly.37840.

Copyright © 2016, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Tanner RM, Shimbo D, Dreisbach AW, Carson AP, Fox ER, Muntner P. Association between 24-hour blood pressure variability and chronic kidney disease: a cross-sectional analysis of African Americans participating in the Jackson heart study. BMC Nephrol. 2015; 16: 84[DOI][PubMed]
  • 2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351(13): 1296-305[DOI][PubMed]
  • 3. Huang WC, Levey AS, Serio AM, Snyder M, Vickers AJ, Raj GV, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006; 7(9): 735-40[DOI][PubMed]
  • 4. Yang HC, Zuo Y, Fogo AB. Models of chronic kidney disease. Drug Discov Today Dis Models. 2010; 7(1-2): 13-9[DOI][PubMed]
  • 5. Conn PM. Sourcebook of models for biomedical research. 2007;
  • 6. Kujal P, Vernerova Z. [5/6 nephrectomy as an experimental model of chronic renal failure and adaptation to reduced nephron number]. Cesk Fysiol. 2008; 57(4): 104-9[PubMed]
  • 7. Bakris GL. Slowing nephropathy progression: focus on proteinuria reduction. Clin J Am Soc Nephrol. 2008; 3 Suppl 1-10[DOI][PubMed]
  • 8. Paige NM, Nagami GT. The top 10 things nephrologists wish every primary care physician knew. Mayo Clin Proc. 2009; 84(2): 180-6[DOI][PubMed]
  • 9. Ray L, Nanda SK, Chatterjee A, Sarangi R, Ganguly S. A comparative study of serum aminotransferases in chronic kidney disease with and without end-stage renal disease: Need for new reference ranges. Int J Appl Basic Med Res. 2015; 5(1): 31-5[DOI][PubMed]
  • 10. Vrtovsnik F, Coester AM, Lopes-Barreto D, de Waart DR, Van der Wal AC, Struijk DG, et al. Induction of chronic kidney failure in a long-term peritoneal exposure model in the rat: effects on functional and structural peritoneal alterations. Perit Dial Int. 2010; 30(5): 558-69[DOI][PubMed]
  • 11. Sviglerova J, Kuncova J, Nalos L, Tonar Z, Rajdl D, Stengl M. Cardiovascular parameters in rat model of chronic renal failure induced by subtotal nephrectomy. Physiol Res. 2010; 59 Suppl 1-8[PubMed]
  • 12. Litbarg NO, Vujicic S, Setty S, Sethupathi P, Dunea G, Arruda JA. A novel model of surgical injury in adult rat kidney: a "pouch model. Sci Rep. 2013; 3: 2890
  • 13. Chang ZT, Hong L, Wang H, Lai HL, Li LF, Yin QL. Application of peripheral-blood-derived endothelial progenitor cell for treating ischemia-reperfusion injury and infarction: a preclinical study in rat models. J Cardiothorac Surg. 2013; 8: 33[DOI][PubMed]
  • 14. Ferrari GO, Ferreira JC, Cavallari RT, Neves KR, dos Reis LM, Dominguez WV, et al. Mineral bone disorder in chronic kidney disease: head-to-head comparison of the 5/6 nephrectomy and adenine models. BMC Nephrol. 2014; 15: 69[DOI][PubMed]
  • 15. Middleton JP, Pun PH. Hypertension, chronic kidney disease, and the development of cardiovascular risk: a joint primacy. Kidney Int. 2010; 77(9): 753-5[DOI][PubMed]
  • 16. Borrelli S, De Nicola L, Stanzione G, Conte G, Minutolo R. Resistant hypertension in nondialysis chronic kidney disease. Int J Hypertens. 2013; 2013: 929183[DOI][PubMed]
  • 17. Bidani AK, Polichnowski AJ, Loutzenhiser R, Griffin KA. Renal microvascular dysfunction, hypertension and CKD progression. Curr Opin Nephrol Hypertens. 2013; 22(1): 1-9[DOI][PubMed]
  • 18. Loutzenhiser R, Griffin K, Williamson G, Bidani A. Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms. Am J Physiol Regul Integr Comp Physiol. 2006; 290(5)-67[DOI][PubMed]
  • 19. Yamamoto S, Kido R, Onishi Y, Fukuma S, Akizawa T, Fukagawa M, et al. Use of renin-angiotensin system inhibitors is associated with reduction of fracture risk in hemodialysis patients. PLoS One. 2015; 10(4)[DOI][PubMed]
  • 20. Ewen S, Ukena C, Linz D, Schmieder RE, Bohm M, Mahfoud F. The sympathetic nervous system in chronic kidney disease. Curr Hypertens Rep. 2013; 15(4): 370-6[DOI][PubMed]
  • 21. Trujillo J, Chirino YI, Molina-Jijon E, Anderica-Romero AC, Tapia E, Pedraza-Chaverri J. Renoprotective effect of the antioxidant curcumin: Recent findings. Redox Biol. 2013; 1: 448-56[DOI][PubMed]
  • 22. Martin WF, Armstrong LE, Rodriguez NR. Dietary protein intake and renal function. Nutr Metab (Lond). 2005; 2: 25[DOI][PubMed]
  • 23. Yasuda K, Okuda K, Endo N, Ishiwatari Y, Ikeda R, Hayashi H, et al. Hypoaminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal. Gastroenterology. 1995; 109(4): 1295-300[PubMed]
  • 24. Mustafa LA, Al-Abachi SB, Khalaf DS. Some biochemical changes in serum of hemodialysis patients. Natl J Chem. 2008; 32: 695-700
  • 25. Lopes EP, Sette LH, Sette JB, Luna CF, Andrade AM, Moraes M, et al. Serum alanine aminotransferase levels, hematocrit rate and body weight correlations before and after hemodialysis session. Clinics (Sao Paulo). 2009; 64(10): 941-5[DOI][PubMed]
  • 26. Trevizoli JE, de Paula Menezes R, Ribeiro Velasco LF, Amorim R, de Carvalho MB, Mendes LS, et al. Hepatitis C is less aggressive in hemodialysis patients than in nonuremic patients. Clin J Am Soc Nephrol. 2008; 3(5): 1385-90[DOI][PubMed]
  • 27. Cotler SJ, Diaz G, Gundlapalli S, Jakate S, Chawla A, Mital D, et al. Characteristics of hepatitis C in renal transplant candidates. J Clin Gastroenterol. 2002; 35(2): 191-5[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments